698 related articles for article (PubMed ID: 27834856)
41. Drug Redeployment to Kill Leukemia and Lymphoma Cells by Disrupting SCD1-Mediated Synthesis of Monounsaturated Fatty Acids.
Southam AD; Khanim FL; Hayden RE; Constantinou JK; Koczula KM; Michell RH; Viant MR; Drayson MT; Bunce CM
Cancer Res; 2015 Jun; 75(12):2530-40. PubMed ID: 25943877
[TBL] [Abstract][Full Text] [Related]
42. Stearoyl-CoA Desaturase 1 (SCD1) is a key factor mediating diabetes in MyD88-deficient mice.
Yokoyama S; Hosoi T; Ozawa K
Gene; 2012 Apr; 497(2):340-3. PubMed ID: 22326531
[TBL] [Abstract][Full Text] [Related]
43. Intrarenal renin-angiotensin system mediates fatty acid-induced ER stress in the kidney.
Li C; Lin Y; Luo R; Chen S; Wang F; Zheng P; Levi M; Yang T; Wang W
Am J Physiol Renal Physiol; 2016 Mar; 310(5):F351-63. PubMed ID: 26672616
[TBL] [Abstract][Full Text] [Related]
44. Protein O-GlcNAcylation Is Essential for the Maintenance of Renal Energy Homeostasis and Function
Sugahara S; Kume S; Chin-Kanasaki M; Tomita I; Yasuda-Yamahara M; Yamahara K; Takeda N; Osawa N; Yanagita M; Araki SI; Maegawa H
J Am Soc Nephrol; 2019 Jun; 30(6):962-978. PubMed ID: 31043434
[TBL] [Abstract][Full Text] [Related]
45. Stearoyl-CoA desaturase 1 as a therapeutic target for cancer: a focus on hepatocellular carcinoma.
Raeisi M; Hassanbeigi L; Khalili F; Kharrati-Shishavan H; Yousefi M; Mehdizadeh A
Mol Biol Rep; 2022 Sep; 49(9):8871-8882. PubMed ID: 35906508
[TBL] [Abstract][Full Text] [Related]
46. Vitamin A deficiency induces endoplasmic reticulum stress and apoptosis in pancreatic islet cells: Implications of stearoyl-CoA desaturase 1-mediated oleic acid synthesis.
Raja Gopal Reddy M; Mullapudi Venkata S; Putcha UK; Jeyakumar SM
Exp Cell Res; 2018 Mar; 364(1):104-112. PubMed ID: 29409806
[TBL] [Abstract][Full Text] [Related]
47. Investigation of the putative rate-limiting role of electron transfer in fatty acid desaturation using transfected HEK293T cells.
Zámbó V; Simon-Szabó L; Sarnyai F; Mátyási J; Gór-Nagy Z; Somogyi A; Szelényi P; Kereszturi É; Tóth B; Csala M
FEBS Lett; 2020 Feb; 594(3):530-539. PubMed ID: 31557308
[TBL] [Abstract][Full Text] [Related]
48. BTG1 ameliorates liver steatosis by decreasing stearoyl-CoA desaturase 1 (SCD1) abundance and altering hepatic lipid metabolism.
Xiao F; Deng J; Guo Y; Niu Y; Yuan F; Yu J; Chen S; Guo F
Sci Signal; 2016 May; 9(428):ra50. PubMed ID: 27188441
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of stearoyl-CoA desaturase-1 in differentiating 3T3-L1 preadipocytes upregulates elongase 6 and downregulates genes affecting triacylglycerol synthesis.
Ralston JC; Badoud F; Cattrysse B; McNicholas PD; Mutch DM
Int J Obes (Lond); 2014 Nov; 38(11):1449-56. PubMed ID: 24566853
[TBL] [Abstract][Full Text] [Related]
50. SCD1 is the critical signaling hub to mediate metabolic diseases: Mechanism and the development of its inhibitors.
Sun Q; Xing X; Wang H; Wan K; Fan R; Liu C; Wang Y; Wu W; Wang Y; Wang R
Biomed Pharmacother; 2024 Jan; 170():115586. PubMed ID: 38042113
[TBL] [Abstract][Full Text] [Related]
51. SCD1 deficiency protects mice against ethanol-induced liver injury.
Lounis MA; Escoula Q; Veillette C; Bergeron KF; Ntambi JM; Mounier C
Biochim Biophys Acta; 2016 Nov; 1861(11):1662-1670. PubMed ID: 27477676
[TBL] [Abstract][Full Text] [Related]
52. Aberrant lipid metabolism in anaplastic thyroid carcinoma reveals stearoyl CoA desaturase 1 as a novel therapeutic target.
von Roemeling CA; Marlow LA; Pinkerton AB; Crist A; Miller J; Tun HW; Smallridge RC; Copland JA
J Clin Endocrinol Metab; 2015 May; 100(5):E697-709. PubMed ID: 25675381
[TBL] [Abstract][Full Text] [Related]
53. Gene expression profiling in skeletal muscle of Zucker diabetic fatty rats: implications for a role of stearoyl-CoA desaturase 1 in insulin resistance.
Voss MD; Beha A; Tennagels N; Tschank G; Herling AW; Quint M; Gerl M; Metz-Weidmann C; Haun G; Korn M
Diabetologia; 2005 Dec; 48(12):2622-30. PubMed ID: 16284748
[TBL] [Abstract][Full Text] [Related]
54. Aryl hydrocarbon receptor-mediated induction of Stearoyl-CoA desaturase 1 alters hepatic fatty acid composition in TCDD-elicited steatosis.
Angrish MM; Jones AD; Harkema JR; Zacharewski TR
Toxicol Sci; 2011 Dec; 124(2):299-310. PubMed ID: 21890736
[TBL] [Abstract][Full Text] [Related]
55. Metabolic reprogramming of the heart through stearoyl-CoA desaturase.
Dobrzyn P; Bednarski T; Dobrzyn A
Prog Lipid Res; 2015 Jan; 57():1-12. PubMed ID: 25482956
[TBL] [Abstract][Full Text] [Related]
56. Induction of stearoyl-CoA desaturase protects human arterial endothelial cells against lipotoxicity.
Peter A; Weigert C; Staiger H; Rittig K; Cegan A; Lutz P; Machicao F; Häring HU; Schleicher E
Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E339-49. PubMed ID: 18523127
[TBL] [Abstract][Full Text] [Related]
57. Relationship between stearoyl-CoA desaturase 1 gene expression, relative protein abundance, and its fatty acid products in bovine tissues.
Rezamand P; Watts JS; Yavah KM; Mosley EE; Ma L; Corl BA; McGuire MA
J Dairy Res; 2014 Aug; 81(3):333-9. PubMed ID: 24904960
[TBL] [Abstract][Full Text] [Related]
58. Critical role of stearoyl-CoA desaturase-1 (SCD1) in the onset of diet-induced hepatic insulin resistance.
Gutiérrez-Juárez R; Pocai A; Mulas C; Ono H; Bhanot S; Monia BP; Rossetti L
J Clin Invest; 2006 Jun; 116(6):1686-95. PubMed ID: 16741579
[TBL] [Abstract][Full Text] [Related]
59. SCD1 activity in muscle increases triglyceride PUFA content, exercise capacity, and PPARδ expression in mice.
Rogowski MP; Flowers MT; Stamatikos AD; Ntambi JM; Paton CM
J Lipid Res; 2013 Oct; 54(10):2636-46. PubMed ID: 23918045
[TBL] [Abstract][Full Text] [Related]
60. Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase-1.
Jiang G; Li Z; Liu F; Ellsworth K; Dallas-Yang Q; Wu M; Ronan J; Esau C; Murphy C; Szalkowski D; Bergeron R; Doebber T; Zhang BB
J Clin Invest; 2005 Apr; 115(4):1030-8. PubMed ID: 15761499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
